Lokus Healthcare’s mission is to take an active part in the research, development and clinical application of products and services in the fields of Tissue and Cell Therapies that will shape the future of medicine.
Lokus has taken primary role in visioning, founding and management of some of the major establishments active in genetic diagnosis, cell therapy and stem cell banking in Turkey. We have long experience with production of therapeutic cell therapy products and allografts in GMP facilities for medical use.
Lokus is in consortium with a group of companies having a large share of the Turkish market of grafting products. Our group companies have been representatives of major International brands and already have a large internal market and have very good ties with West Asia, Middle East, East Europe markets.
Lokus is graduated from Teknopark Istanbul, The Innovation Hub of Turkey )
( ) in 2018